Collegium Pharmaceutical Inc. (COLL)

19.00
0.21 1.10
NASDAQ : Health Technology
Prev Close 19.21
Open 19.21
Day Low/High 18.74 / 19.40
52 Wk Low/High 10.01 / 19.99
Volume 177.22K
Avg Volume 397.40K
Exchange NASDAQ
Shares Outstanding 33.52M
Market Cap 638.30M
EPS -1.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Bullish Two Hundred Day Moving Average Cross - COLL

Bullish Two Hundred Day Moving Average Cross - COLL

In trading on Monday, shares of Collegium Pharmaceuticals Inc crossed above their 200 day moving average of $13.19, changing hands as high as $13.23 per share. Collegium Pharmaceuticals Inc shares are currently trading up about 3% on the day.

Collegium To Participate In Upcoming Investor Conferences

Collegium To Participate In Upcoming Investor Conferences

STOUGHTON, Mass., Sept.

Collegium Reports Second Quarter 2019 Financial Results

Collegium Reports Second Quarter 2019 Financial Results

- Xtampza ® ER Net Product Revenues Were $26.0 Million in the Second Quarter of 2019, a 44% Increase Over the Second Quarter of 2018 - - Cash and Cash Equivalents Increased to $148.

Collegium To Host Conference Call To Discuss Second Quarter 2019 Financial Results And Provide Corporate Update

Collegium To Host Conference Call To Discuss Second Quarter 2019 Financial Results And Provide Corporate Update

STOUGHTON, Mass., July 24, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc.

RSI Alert: Collegium Pharmaceuticals (COLL) Now Oversold

RSI Alert: Collegium Pharmaceuticals (COLL) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Collegium Pharmaceuticals Is Now Oversold (COLL)

Collegium Pharmaceuticals Is Now Oversold (COLL)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week Of May 17th Options Trading For Collegium Pharmaceuticals (COLL)

First Week Of May 17th Options Trading For Collegium Pharmaceuticals (COLL)

Investors in Collegium Pharmaceuticals Inc saw new options become available this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the COLL options chain for the new May 17th contracts and identified one put and one call contract of particular interest.

First Week Of COLL April 18th Options Trading

First Week Of COLL April 18th Options Trading

Investors in Collegium Pharmaceuticals Inc saw new options become available this week, for the April 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the COLL options chain for the new April 18th contracts and identified one put and one call contract of particular interest.

Relative Strength Alert For Collegium Pharmaceuticals

Relative Strength Alert For Collegium Pharmaceuticals

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Relative Strength Alert For Collegium Pharmaceuticals

Relative Strength Alert For Collegium Pharmaceuticals

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Notable Two Hundred Day Moving Average Cross - COLL

Notable Two Hundred Day Moving Average Cross - COLL

In trading on Monday, shares of Collegium Pharmaceuticals Inc crossed below their 200 day moving average of $20.52, changing hands as low as $19.19 per share. Collegium Pharmaceuticals Inc shares are currently trading down about 7% on the day.

Collegium Pharmaceuticals Is Now Oversold (COLL)

Collegium Pharmaceuticals Is Now Oversold (COLL)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMED, BCOV, CLS, DWSN, EDR, EQC, IFF, ONDK, PAGP, PKE, PTR, SJI, SRE, SWM, TRMB, TWIN Downgrades: ANDE, CBT, COLL, FLEX, GPK, GSM, HI, NAP, NTLA, RGS, UONE, UONEK Initiations: ELVT, SNDR Read on to get TheStreet Quant Ratings' detailed report:

Interesting COLL Put And Call Options For May 18th

Investors in Collegium Pharmaceuticals Inc saw new options become available this week, for the May 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the COLL options chain for the new May 18th contracts and identified one put and one call contract of particular interest.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: COLL Downgrades: CIZN, JD, WAGE Initiations: WRD Read on to get TheStreet Quant Ratings' detailed report:

Opioid Litigants Get Boost From Senate Report

Opioid Litigants Get Boost From Senate Report

A report released by Missouri Sen. Claire McCaskill points to $10 million of payments flowing from a group of five opioid-producing companies to 15 patient advocacy groups over a five-year period.

Short Interest In Collegium Pharmaceuticals Declines 10.8%

Short Interest In Collegium Pharmaceuticals Declines 10.8%

The most recent short interest data has been released for the 01/31/2018 settlement date, which shows a 399,020 share decrease in total short interest for Collegium Pharmaceuticals Inc , to 3,298,223, a decrease of 10.79% since 01/12/2018. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

COLL Crosses Above Average Analyst Target

COLL Crosses Above Average Analyst Target

In recent trading, shares of Collegium Pharmaceuticals Inc have crossed above the average analyst 12-month target price of $22.20, changing hands for $23.38/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

First Week of February 16th Options Trading For Collegium Pharmaceuticals (COLL)

First Week of February 16th Options Trading For Collegium Pharmaceuticals (COLL)

Investors in Collegium Pharmaceuticals Inc saw new options begin trading this week, for the February 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the COLL options chain for the new February 16th contracts and identified one put and one call contract of particular interest.

TheStreet Quant Rating: D (Sell)